Calyan Technologies is an early-stage medical-technology company creating a novel approach to managing cardiac rhythm disorders. Our team has over 100+ years of combined experience developing implantable medical devices in the cardiac rhythm management space. The first iteration of Calyan’s technology is an injectable, leadless, wireless single chamber VVIR pacemaker for treatment of bradycardia. Our robust Intellectual Property portfolio and modular product architecture allows for rapid expansion into adjacent Cardiac Rhythm Management markets such as dual-chamber pacing, cardiac resynchronization therapy, and implantable defibrillation therapy. If you are a clinician or a clinical study research site interested in learning more, please contact info@calyantech.com.

Caution: Calyan’s technology is in development stage and is not approved for commercial use in any market, including the US. United States Federal Law restricts the sale, distribution, or use of this device to, by, or on the order of a physician. Carefully read all instructions prior to use. Observe all warnings and precautions noted throughout these instructions. Failure to do so may result in complications. The Calyan Pacing System has been approved for clinical study use in India through the Drug Controller General of India.